BSE: 500126 | NSE: PGHL | Pharmaceuticals & Drugs | Mid Cap
1. Is Procter & Gamble Health Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Procter & Gamble Health Ltd is a good quality company.
2. Is Procter & Gamble Health Ltd undervalued or overvalued?
The key valuation ratios of Procter & Gamble Health Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is Procter & Gamble Health Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Procter & Gamble Health Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Jun'20 | Jun'21 | TTM | |||
| ROCE % ⓘ | 16.9% | 17.5% | 11% | 7.9% | 9.2% | 12.3% | 11.5% | 73.3% | 20.8% | 22.1% | - | ||
| Value Creation Index ⓘ | 0.2 | 0.3 | -0.2 | -0.4 | -0.3 | -0.1 | -0.2 | 4.2 | 0.5 | 0.6 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 590 | 687 | 798 | 867 | 940 | 993 | 698 | 1,288 | 904 | 1,009 | 1,018 | ||
| YoY Gr. Rt. % | - | 16.6% | 16.1% | 8.7% | 8.3% | 5.7% | -29.7% | 84.5% | -29.8% | 11.6% | - | ||
| Adj EPS ⓘ | 38.4 | 47.1 | 33.4 | 25.5 | 31.7 | 46.6 | 48.6 | 502.1 | 102.2 | 106.7 | 104.2 | ||
| YoY Gr. Rt. % | - | 22.6% | -29.1% | -23.4% | 24.2% | 47.1% | 4.2% | 933.8% | -79.6% | 4.4% | - | ||
| BVPS (₹) ⓘ | 247 | 291.4 | 315.1 | 333.9 | 356.4 | 399.9 | 441.7 | 927.8 | 363.2 | 421.6 | 455 | ||
| Adj Net Profit ⓘ | 63.8 | 78.1 | 55.4 | 42.4 | 52.6 | 77.4 | 80.6 | 833 | 170 | 177 | 173 | ||
| Cash Flow from Ops. ⓘ | 18.8 | 54.3 | 0.5 | 5 | 83.5 | 107 | 53.7 | -130 | 157 | 247 | - | ||
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | 6.2% | 1.4% | 13.1% | 11.6% | ||||||||
| Adj EPS ⓘ | 12% | 27.5% | 30% | 4.4% | ||||||||
| BVPS ⓘ | 6.1 | 3.4 | -1.5 | 16.1 | ||||||||
| Share Price | 23.5% | 40% | 15.4% | -28.1% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Jun'20 | Jun'21 | TTM | ||
| Return on Equity % ⓘ | 16.9 | 17.5 | 11 | 7.9 | 9.2 | 12.3 | 11.5 | 73.3 | 20.8 | 22 | 23.8 | |
| Op. Profit Mgn % ⓘ | 12.3 | 15.4 | 9.7 | 6.8 | 9 | 11.7 | 10.1 | 16.3 | 23.4 | 24.4 | 24.2 | |
| Net Profit Mgn % ⓘ | 10.8 | 11.4 | 6.9 | 4.9 | 5.6 | 7.8 | 11.6 | 64.7 | 18.8 | 17.6 | 17 | |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |
| Working Cap Days ⓘ | 273 | 365 | 235 | 248 | 381 | 367 | 503 | 321 | 346 | 491 | 0 | |
| Cash Conv. Cycle ⓘ | 57 | 71 | 74 | 85 | 82 | 66 | 88 | 15 | 12 | 6 | 0 | |
Sales growth is growing at healthy rate in last 3 years 13.05%
Net Profit is growing at healthy rate in last 3 years 29.99%
Sales growth is good in last 4 quarters at 10.69%
Return on Equity has declined versus last 3 years average to 23.80%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 104.2 | - |
| TTM Sales (₹ Cr.) | 1,018 | - |
| BVPS (₹.) ⓘ | 455 | - |
| Reserves (₹ Cr.) ⓘ | 739 | - |
| P/BV ⓘ | 11.18 | - |
| PE ⓘ | 48.83 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 4910.00 / 7499.95 |
| All Time Low / High (₹) | 114.00 / 7499.95 |
| Market Cap (₹ Cr.) | 8,443 |
| Equity (₹ Cr.) | 16.6 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 39.1 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967. It was also the first Merck Group Company to go public in the year 1981. Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country.
On December 1st, 2018, P&G successfully completed the acquisition of Merck’s Consumer Health business further to approval of all relevant regulatory authorities and the fulfilment of other customary closing conditions. Procter & Gamble Overseas India B.V. now holds 51.81% of the share capital in Merck Limited, while the remaining 48.19% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.
Currently, Procter & Gamble Health Limited (formerly Merck Limited) is one of India’s largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life. With a strong portfolio of brands backed by science and trusted by doctors, pharmacists and consumers, Procter & Gamble Health Limited combines the best of P&G and Legacy Merck’s Consumer Health capabilities and cultures. Together we are working towards leveraging our combined expertise to develop categories and brands that meet today’s needs and tomorrow’s opportunities.
Situated at Usgaon, Goa, the company’s Manufacturing Site has grown from a small Vitamin E producing unit to a big composite plant manufacturing pharma and chemical products.
Business area of the company
Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India’s largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life.
Brands of the company
Awards and achievements
My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
